Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 124.00
-4.25 (-3.31%)
At close: May 20, 2025
NSE:ARISTO Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Net Income | 58.76 | 38.96 | 35.62 | 14.34 | 10.76 | 10.07 | Upgrade
|
| Depreciation & Amortization | 20.82 | 15.71 | 15.36 | 10.99 | 7.49 | 5.19 | Upgrade
|
| Other Amortization | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.68 | 0 | - | - | - | - | Upgrade
|
| Other Operating Activities | 16.53 | 16.48 | 26.98 | 25.36 | 25.47 | 29.52 | Upgrade
|
| Change in Accounts Receivable | -669.67 | -129 | -113.73 | -4.35 | 155.4 | -60.42 | Upgrade
|
| Change in Inventory | -151.27 | -94.1 | -64.15 | 75.83 | -76.21 | 86.64 | Upgrade
|
| Change in Accounts Payable | 923.29 | 241.08 | 101.78 | -31.39 | 5.42 | -247.64 | Upgrade
|
| Change in Other Net Operating Assets | -100.79 | -13.13 | -29.7 | -23 | -105.49 | 190.7 | Upgrade
|
| Operating Cash Flow | 96.99 | 76 | -27.84 | 67.78 | 22.84 | 14.07 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 196.75% | 62.34% | -82.73% | Upgrade
|
| Capital Expenditures | -69.81 | -65.55 | -40.61 | -32.49 | -19.89 | -22 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.2 | 0.2 | 2.68 | 0.04 | - | - | Upgrade
|
| Investment in Securities | -0.08 | - | -0.08 | - | - | - | Upgrade
|
| Other Investing Activities | 0.44 | 0.46 | 0.56 | 0.84 | 0.12 | 0.08 | Upgrade
|
| Investing Cash Flow | -68.18 | -66.1 | -37.46 | -31.6 | -19.78 | -21.92 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 13.89 | 34.73 | Upgrade
|
| Long-Term Debt Repaid | - | -1.7 | -9.25 | -9.69 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -10.47 | -1.7 | -9.25 | -9.69 | 13.89 | 34.73 | Upgrade
|
| Issuance of Common Stock | - | - | 130.52 | - | - | - | Upgrade
|
| Common Dividends Paid | -2.72 | -4.43 | - | - | - | - | Upgrade
|
| Other Financing Activities | -15.1 | -15.95 | -41.61 | -23.45 | -21.08 | -26.01 | Upgrade
|
| Financing Cash Flow | -28.29 | -22.07 | 79.66 | -33.14 | -7.19 | 8.73 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - | Upgrade
|
| Net Cash Flow | 0.52 | -12.16 | 14.37 | 3.04 | -4.13 | 0.87 | Upgrade
|
| Free Cash Flow | 27.17 | 10.45 | -68.44 | 35.29 | 2.95 | -7.93 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 1097.18% | - | - | Upgrade
|
| Free Cash Flow Margin | 0.83% | 0.43% | -3.14% | 2.13% | 0.18% | -0.39% | Upgrade
|
| Free Cash Flow Per Share | 3.99 | 1.54 | -12.91 | 7.07 | 0.59 | -1.59 | Upgrade
|
| Cash Interest Paid | 17.65 | 16.67 | 22.07 | 18.82 | 22.09 | 21.44 | Upgrade
|
| Cash Income Tax Paid | 18.81 | 13.87 | 12.62 | -3.5 | 3.45 | 4.06 | Upgrade
|
| Levered Free Cash Flow | 35.22 | 31 | -76.52 | -9.32 | -32.38 | -55 | Upgrade
|
| Unlevered Free Cash Flow | 45.66 | 41.43 | -62.72 | 2.44 | -18.57 | -41.6 | Upgrade
|
| Change in Net Working Capital | -35.98 | -47.56 | 82.85 | 1.9 | 28.65 | 49.73 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.